Role of mesenchymal stem cells in hematopoietic stem cell transplantation

Current Opinion in Hematology

Volumn 7, Issue 6, 2000, Pages 358-363

  Devine, Steven M ^a   Hoffman, Ron ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b M/C 734 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; DNA MODIFICATION; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOMODULATION; MESENCHYME; MESENCHYME CELL; PRIORITY JOURNAL; REVIEW; STROMA CELL;

ANIMALS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MESODERM; STEM CELLS; STROMAL CELLS;

EID: 0033793258     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200011000-00007     Document Type: Review

References (57)

1. Stromal cell associated haemopoiesis
2. Lineage of osteogenic cells and their relationship to the stromal system
3. Marrow stromal stem cells
4. Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma
5. Stromal cells in long-term cultures: Keys to the elucidation of hematopoietic development?
6. Confocal images of marrow stromal (Westen-Bainton) cells
7. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation
8. Improved hematopoiesis in anemic Sl/Sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment
9. Signaling through the interaction of membrane-restricted stem cell factor and c-kit receptor tyrosine kinase: Genetic evidence for a differential role in erythropoiesis
10. Lack of recovery of murine hematopoietic stromal cells after irradiation-induced damage
11. Effects of radiation on hematopoietic stroma
12. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors
13. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation
14. Bone marrow stromal function from patients after bone marrow transplantation
15. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients
16. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo
17. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells
18. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero
19. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation
20. Host origin of marrow stromal cells following allogeneic bone marrow transplantation
21. Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation
22. Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans
23. The origin of stromal cells in patients treated by bone marrow transplantation
24. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia
25. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases
26. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
27. Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man
28. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections
29. Multilineage potential of adult human mesenchymal stem cells
30. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
31. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells
32. Mesenchymal stem cells: No longer second class marrow citizens
33. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo
34. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method
35. Mesenchymal stem cells
36. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow
37. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation
38. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells
39. Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate
40. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice
41. Evidence of allogeneic stromal engraftment in bone marrow using canine mesenchymal stem cells
42. Studies of mesenchymal stem cells in non-human primates: Evaluation of toxicity and engraftment
43. Human mesenchymal stem cells can enhance human CD34+ cell repopulating of NOD/SCID mice
44. Human mesenchymal stem cells induce unresponsiveness in preactivated but not naive alloantigen specific T cells
45. Mesenchymal stem cells can prolong skin graft survival in the baboon
46. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use
47. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
48. Marrow stromal cells as stem cells for nonhematopoietic tissues
49. Marrow stromal cells as stem cells for continual renewal of nonhematopoietic tissues and as potential vectors for gene therapy
50. Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells
51. Multipotential marrow stromal cells transduced to produce L-DOPA: Engraftment in a rat model of Parkinson disease
52. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
53. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells
54. Human erythropoietin gene delivery using adult mesenchymal stem cells can prevent drug induced anemia in NOD/SCID mouse model
55. Genetically modified mesenchymal stem cells can effectively deliver bioactive erythropoietin in the baboon
56. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: In vivo detection of transduced cells without myeloablation
57. Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning